A carregar...

Biophysical Differences between Chronic Myelogenous Leukemic Quiescent and Proliferating Stem/Progenitor Cells

The treatment of chronic myeloid leukemia (CML), a clonal myeloproliferative disorder has improved recently, but most patients have not yet been cured. Some patients develop resistance to the available tyrosine kinase treatments. Persistence of residual quiescent CML stem cells (LSC) that later resu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Guz, Nataliia V., Patel, Sapan J., Dokukin, Maxim E., Clarkson, Bayard, Sokolov, Igor
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116407/
https://ncbi.nlm.nih.gov/pubmed/27431055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.06.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!